Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 71Breast Neoplasms 45Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 21Neoplasm Metastasis 14Adenocarcinoma 13Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Colorectal Neoplasms 8Melanoma 7Carcinoma 7Head and Neck Neoplasms 6Digestive System Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Pancreatic Diseases 5Pancreatic Adenocarcinoma 5Ovarian Neoplasms 5Digestive System Diseases 5Carcinoma, Pancreatic Ductal 5Stomach Neoplasms 4Sarcoma 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms by Site 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Endocrine Gland Neoplasms 4Carcinoma, Squamous Cell 4

Interventions

spartalizumab 1canakinumab 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Pancreatic Ductal Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT04581343 2025-05-04

PanCAN-SR1

Pancreatic Cancer Action Network

Phase 1 Completed
10 enrolled 26 charts
Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡